Yale Smoking Cessation and Alcohol Treatment Research Clinic at CMHC

Mission

To develop and evaluate treatments for smoking and for problematic alcohol consumption.

Presently we are conducting an alcohol treatment study called the ADVANCE study.

The ADVANCE Study

This is a treatment study examining the use of Varenicline (Chantix) to reduce alcohol consumption among heavy drinkers who smoke cigarettes. Click here to go to the ADVANCE study website.

Who is eligible for the ADVANCE study?

  • Adults 18-70 years old.
  • Those who want to reduce or stop your alcohol use.
  • Those who smoke cigarettes.
  • Meet other inclusion criteria for the study.

Location

SATU
1 Long Wharf Drive, Suite 18
New Haven, CT  06511

Yale Faculty

Lisa Fucito

Assistant Professor of Psychiatry

Program Director Smoking Cessation Service Smilow Cancer Hospital at Yale-New Haven

Robert F. Leeman

Assistant Professor of Psychiatry

Stephanie Samples O'Malley

Professor of Psychiatry

Director, Division of Substance Abuse Research in Psychiatry

Deputy Chair, Clinical Research

Benjamin A. Toll

Lecturer in Psychiatry

Program Director, Smoking Cessation Service at Smilow Cancer Hospital at Yale-New Haven

Contact Us

For more information about the ADVANCE study, call Susan at 203-974-5768 or email advance@yale.edu.